The 1 analysts offering 12-month price forecasts for LifeVantage Corp have a median target of 9.50, with a high estimate of 9.50 and a low estimate of 9.50. The median estimate represents a +22.74% increase from the last price of 7.74.
The current consensus among 1 polled investment analysts is to Hold stock in LifeVantage Corp. This rating has held steady since November, when it was downgraded from a Buy rating.Move your mouse over past months for detail
Earnings and Sales Forecasts
Earnings per Share $0.20
Reporting Date Aug 18
Earnings per Share
Move your mouse over a quarter or year to see how estimates have changed over time.